Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601-Reference-Cited by-同舟云学术

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601

Published:2015-10-22 Issue:2 Volume:172 Page:208-218
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Till Brian G.¹²,Li Hongli³,Bernstein Steven H.⁴,Fisher Richard I.⁵,Burack W. Richard⁴,Rimsza Lisa M.⁶,Floyd Justin D.⁷,DaSilva Marco A.⁸,Moore Dennis F.⁹,Pozdnyakova Olga¹⁰,Smith Sonali M.¹¹,LeBlanc Michael³,Friedberg Jonathan W.⁴

Affiliation:

1. Fred Hutchinson Cancer Research Center; Seattle WA USA

2. University of Washington Medical Center; Seattle WA USA

3. SWOG Statistical Center; Seattle WA USA

4. James P. Wilmot Cancer Center; University of Rochester; Rochester NY USA

5. Fox Chase Cancer Center; Temple University School of Medicine; Philadelphia PA USA

6. Arizona Cancer Center; University of Arizona; Tucson AZ USA

7. Heartland NCORP/Saint Francis Medical Center; Cape Girardeau MO USA

8. Southeast Cancer Consortium-Upstate NCORP/Kingsport Hem & Onc Associates; Kingsport TN USA

9. Wichita NCORP/Cancer Center of Kansas; Wichita KS USA

10. Brigham and Women's Hospital; Boston MA USA

11. University of Chicago Hospitals; Chicago IL USA

Funder

National Cancer Institute

National Clinical Trials Network (NCTN)

National Institutes of Health

Millennium Pharmaceuticals, Inc.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13818/fullpdf

Reference45 articles.

1. Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study;Abrahamsson;Blood,2014

2. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA;Aschebrook-Kilfoy;Leukemia & Lymphoma,2013

3. A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150;Belch;Annals of Oncology,2007

4. Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells;Bogner;British Journal of Haematology,2003

5. Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach;Bogner;Leukemia & Lymphoma,2006

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in the Treatment of Non Hodgkin’s Lymphoma;Journal of Clinical Personalized Medicine;2024

2. Clinical Experience on Proteasome Inhibitors in Cancer;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15

3. Frontline Therapy in Mantle Cell Lymphoma: When Clinical Trial and Real-World Data Collide;Journal of Clinical Oncology;2023-01-20

4. Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial;Clinical Lymphoma Myeloma and Leukemia;2022-12

5. Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies;Leukemia & Lymphoma;2022-06-15